164 related articles for article (PubMed ID: 34124983)
1. Protective role of astragaloside IV in gastric cancer through regulation of microRNA-195-5p-mediated PD-L1.
Liu W; Chen H; Wang D
Immunopharmacol Immunotoxicol; 2021 Aug; 43(4):443-451. PubMed ID: 34124983
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-6884-5p Regulates the Proliferation, Invasion, and EMT of Gastric Cancer Cells by Directly Targeting S100A16.
Lv H; Hou H; Lei H; Nie C; Chen B; Bie L; Han L; Chen X
Oncol Res; 2020 May; 28(3):225-236. PubMed ID: 31796150
[TBL] [Abstract][Full Text] [Related]
3. microRNA-665 is down-regulated in gastric cancer and inhibits proliferation, invasion, and EMT by targeting PPP2R2A.
Zhang M; Wang S; Yi A; Qiao Y
Cell Biochem Funct; 2020 Jun; 38(4):409-418. PubMed ID: 31923339
[TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus-encoded miR-BART5-5p upregulates PD-L1 through PIAS3/pSTAT3 modulation, worsening clinical outcomes of PD-L1-positive gastric carcinomas.
Yoon CJ; Chang MS; Kim DH; Kim W; Koo BK; Yun SC; Kim SH; Kim YS; Woo JH
Gastric Cancer; 2020 Sep; 23(5):780-795. PubMed ID: 32206940
[TBL] [Abstract][Full Text] [Related]
5. Dual targeting of PD-L1 and PD-L2 by PCED1B-AS1 via sponging hsa-miR-194-5p induces immunosuppression in hepatocellular carcinoma.
Fan F; Chen K; Lu X; Li A; Liu C; Wu B
Hepatol Int; 2021 Apr; 15(2):444-458. PubMed ID: 33219943
[TBL] [Abstract][Full Text] [Related]
6. CircSCUBE3 Reduces the Anti-gastric Cancer Activity of Anti-PD-L1.
Shan H; Zhang X; Zhang X; Wei Y; Meng L; Li J; Zhang Z; Ma L; Xiao Y
Mol Biotechnol; 2024 Jan; 66(1):123-137. PubMed ID: 37052807
[TBL] [Abstract][Full Text] [Related]
7. Circular RNA ITCH suppresses metastasis of gastric cancer via regulating miR-199a-5p/Klotho axis.
Wang Y; Wang H; Zheng R; Wu P; Sun Z; Chen J; Zhang L; Zhang C; Qian H; Jiang J; Xu W
Cell Cycle; 2021; 20(5-6):522-536. PubMed ID: 33499704
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of miR-15b-5p promotes gastric cancer metastasis by regulating PAQR3.
Zhao C; Li Y; Chen G; Wang F; Shen Z; Zhou R
Oncol Rep; 2017 Jul; 38(1):352-358. PubMed ID: 28560431
[TBL] [Abstract][Full Text] [Related]
9. Astragaloside IV inhibits TGF-β1-induced epithelial-mesenchymal transition through inhibition of the PI3K/Akt/NF-κB pathway in gastric cancer cells.
Zhu J; Wen K
Phytother Res; 2018 Jul; 32(7):1289-1296. PubMed ID: 29480652
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA -383-5p restrains the proliferation and migration of breast cancer cells and promotes apoptosis via inhibition of PD-L1.
Azarbarzin S; Hosseinpour-Feizi MA; Banan Khojasteh SM; Baradaran B; Safaralizadeh R
Life Sci; 2021 Feb; 267():118939. PubMed ID: 33359245
[TBL] [Abstract][Full Text] [Related]
11. Astragaloside IV inhibits pathological functions of gastric cancer-associated fibroblasts.
Wang ZF; Ma DG; Zhu Z; Mu YP; Yang YY; Feng L; Yang H; Liang JQ; Liu YY; Liu L; Lu HW
World J Gastroenterol; 2017 Dec; 23(48):8512-8525. PubMed ID: 29358859
[TBL] [Abstract][Full Text] [Related]
12. Hsa_circ_0017639 expression promotes gastric cancer proliferation and metastasis by sponging miR-224-5p and upregulating USP3.
Li B; Jin M; Cao F; Li J; Wu J; Xu L; Liu X; Shi Y; Chen W
Gene; 2020 Aug; 750():144753. PubMed ID: 32376451
[TBL] [Abstract][Full Text] [Related]
13. Propofol Reduces Epithelial to Mesenchymal Transition, Invasion and Migration of Gastric Cancer Cells through the MicroRNA-195-5p/Snail Axis.
Liu F; Qiu F; Fu M; Chen H; Wang H
Med Sci Monit; 2020 Mar; 26():e920981. PubMed ID: 32115570
[TBL] [Abstract][Full Text] [Related]
14. Astragaloside IV Induced miR-134 Expression Reduces EMT and Increases Chemotherapeutic Sensitivity by Suppressing CREB1 Signaling in Colorectal Cancer Cell Line SW-480.
Ye Q; Su L; Chen D; Zheng W; Liu Y
Cell Physiol Biochem; 2017; 43(4):1617-1626. PubMed ID: 29041002
[TBL] [Abstract][Full Text] [Related]
15. Astragaloside IV alleviates atherosclerosis through targeting circ_0000231/miR-135a-5p/CLIC4 axis in AS cell model in vitro.
Shao X; Liu Z; Liu S; Lin N; Deng Y
Mol Cell Biochem; 2021 Apr; 476(4):1783-1795. PubMed ID: 33439448
[TBL] [Abstract][Full Text] [Related]
16. Bone marrow mesenchymal stromal cells attenuate liver allograft rejection may via upregulation PD-L1 expression through downregulation of miR-17-5p.
Chen Q; Zhou R; Zhang Y; Zhu S; Xiao C; Gong J; Li K; Tang H; Sun C; Zhang J
Transpl Immunol; 2018 Dec; 51():21-29. PubMed ID: 30092337
[TBL] [Abstract][Full Text] [Related]
17. Astragaloside IV suppresses development of hepatocellular carcinoma by regulating miR-150-5p/β-catenin axis.
Cui X; Jiang X; Wei C; Xing Y; Tong G
Environ Toxicol Pharmacol; 2020 Aug; 78():103397. PubMed ID: 32417721
[TBL] [Abstract][Full Text] [Related]
18. miR-129-5p attenuates cell proliferation and epithelial mesenchymal transition via HMGB1 in gastric cancer.
Wang S; Chen Y; Yu X; Lu Y; Wang H; Wu F; Teng L
Pathol Res Pract; 2019 Apr; 215(4):676-682. PubMed ID: 30635217
[TBL] [Abstract][Full Text] [Related]
19. Astragaloside IV attenuates hypoxia/reoxygenation injury-induced apoptosis of type II alveolar epithelial cells through miR-21-5p.
Li H; Yao C; Shi K; Zhao Y; Du J; Hu D; Liu Z
Bioengineered; 2021 Dec; 12(1):7747-7754. PubMed ID: 34617873
[TBL] [Abstract][Full Text] [Related]
20. MiR-30c-5p suppresses migration, invasion and epithelial to mesenchymal transition of gastric cancer via targeting MTA1.
Cao JM; Li GZ; Han M; Xu HL; Huang KM
Biomed Pharmacother; 2017 Sep; 93():554-560. PubMed ID: 28686969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
